A Plain Language Summary of the ASCENT Study: Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer

Authors:
  • JCJanice Cowden
    Janice Cowden

Abstract
Sacituzumab Govitecan (also known by the brand name TRODELVY®) is a new and available treatment for metastatic triple-negative breast cancer, or mTNBC for short. Metastatic breast cancer means the ...
Funding Information
  • Gilead Sciences, Inc